DECO: decompose heterogeneous population cohorts for patient stratification and discovery of sample biomarkers using omic data profiling
暂无分享,去创建一个
Javier De Las Rivas | Matthew W. Trotter | Remco Loos | Francisco J. Campos-Laborie | Alberto Risueño | M. Ortiz-Estévez | B. Rosón-Burgo | Conrad Droste | Celia Fontanillo | J. M. Sánchez-Santos | M. Trotter | C. Fontanillo | J. Rivas | F. Campos-Laborie | J. Sánchez-Santos | Remco Loos | A. Risueño | C. Droste | B. Rosón-Burgo | M. Ortiz-Estévez | J De Las Rivas | R. Loos | J. Sánchez‐Santos
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] Gordon K Smyth,et al. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.
[3] C. Sotiriou,et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures , 2007, Breast Cancer Research.
[4] Greg Tucker-Kellogg,et al. A Comparison of Methods for Data-Driven Cancer Outlier Discovery, and An Application Scheme to Semisupervised Predictive Biomarker Discovery , 2011, Cancer informatics.
[5] K. Morik,et al. Robust Selection of Cancer Survival Signatures from High-Throughput Genomic Data Using Two-Fold Subsampling , 2014, PloS one.
[6] Zihua Yang,et al. Prediction of heterogeneous differential genes by detecting outliers to a Gaussian tight cluster , 2013, BMC Bioinformatics.
[7] Mark J. Ratain,et al. Tumour heterogeneity in the clinic , 2013, Nature.
[8] J. Lebbink,et al. Semi-quantitative proteomics of mammalian cells upon short-term exposure to non-ionizing electromagnetic fields , 2017, PloS one.
[9] Lorena Díaz-González,et al. Comparative Performance of Four Single Extreme Outlier Discordancy Tests from Monte Carlo Simulations , 2014, TheScientificWorldJournal.
[10] Yutaka Saito,et al. Epigenetic silencing of V(D)J recombination is a major determinant for selective differentiation of mucosal-associated invariant t cells from induced pluripotent stem cells , 2017, PloS one.
[11] Melissa A. Troester,et al. Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification , 2016, Breast Cancer Research.
[12] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[13] E. Mastriani,et al. Microarray-Based MicroRNA Expression Data Analysis with Bioconductor. , 2018, Methods in molecular biology.
[14] J. Wang,et al. Identification of MAGEA12 as a prognostic outlier gene in gastric cancers. , 2016, Neoplasma.
[15] R. Gillies,et al. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work , 2012, Nature Reviews Cancer.
[16] A. Sieuwerts,et al. The challenge of gene expression profiling in heterogeneous clinical samples. , 2013, Methods.
[17] Eric J. Beh,et al. Correspondence Analysis: Theory, Practice and New Strategies , 2014 .
[18] Jane Fridlyand,et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.
[19] Xing Qiu,et al. Assessing stability of gene selection in microarray data analysis , 2006, BMC Bioinformatics.
[20] Meng-zhu Xue,et al. Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer , 2017, Nature Communications.
[21] Peter Ghazal,et al. Multi-Factorial Analysis of Class Prediction Error: Estimating Optimal Number of Biomarkers for Various Classification Rules , 2010, J. Bioinform. Comput. Biol..
[22] Y. Tomer,et al. DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. , 2014, Journal of autoimmunity.
[23] J. A. Hartigan,et al. A k-means clustering algorithm , 1979 .
[24] David Hsiang,et al. Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study. , 2009, Journal of biomedical optics.
[25] S. Gore,et al. Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling? , 2014, Expert review of hematology.
[26] Steven J. M. Jones,et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer , 2015, Cell.
[27] Andrew J. Kavran,et al. Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells* , 2017, Molecular & Cellular Proteomics.
[28] Sambasivarao Damaraju,et al. Effects of Sample Size on Differential Gene Expression, Rank Order and Prediction Accuracy of a Gene Signature , 2013, PloS one.
[29] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[30] Baolin Wu,et al. Cancer outlier differential gene expression detection. , 2007, Biostatistics.
[31] Donna K. Slonim,et al. CSAX: Characterizing Systematic Anomalies in eXpression Data , 2014, RECOMB.
[32] B. Margolin,et al. An Analysis of Variance for Categorical Data , 1971 .
[33] E. Andres Houseman,et al. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age , 2017, Breast Cancer Research.
[34] M. Kendall. Statistical Methods for Research Workers , 1937, Nature.
[35] G. Babu. Subsample and half-sample methods , 1992 .
[36] Debashis Ghosh,et al. COPA - cancer outlier profile analysis , 2006, Bioinform..
[37] Pedro Carmona-Saez,et al. mCSEA: Detecting subtle differentially methylated regions , 2018, bioRxiv.
[38] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..
[39] L. Esserman,et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. , 2011, JAMA.
[40] C. Kahn,et al. Adipose-Derived Circulating miRNAs Regulate Gene Expression in Other Tissues , 2017, Nature.
[41] Daria A. Gaykalova,et al. Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC , 2017, Oncotarget.
[42] P. Afonso,et al. Proteomic analysis of plasma extracellular vesicles reveals mitochondrial stress upon HTLV-1 infection , 2018, Scientific Reports.
[43] Charity W. Law,et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.
[44] P. Gonzalez-Alegre,et al. Towards precision medicine , 2017 .
[45] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[46] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[47] L. Wessels,et al. Defining chromosomal translocation risks in cancer , 2016, Proceedings of the National Academy of Sciences.
[48] Albert Sickmann,et al. Current strategies and findings in clinically relevant post-translational modification-specific proteomics , 2015, Expert review of proteomics.
[49] H. Lian. MOST: detecting cancer differential gene expression. , 2007, Biostatistics.
[50] Javier De Las Rivas,et al. GATExplorer: Genomic and Transcriptomic Explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs , 2010, BMC Bioinformatics.
[51] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] E P Noble,et al. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients , 2014, Translational Psychiatry.
[53] Michele De Palma,et al. The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities , 2012, Molecular oncology.
[54] M. Sivabalakrishnan,et al. Feature Selection of Gene Expression Data for Cancer Classification: A Review , 2015 .
[55] Mark A. Ragan,et al. mCOPA: analysis of heterogeneous features in cancer expression data , 2012, Journal of Clinical Bioinformatics.
[56] Michael P. Schroeder,et al. In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities. , 2015, Cancer cell.
[57] Guillem Rigaill,et al. Identifying subgroup markers in heterogeneous populations , 2013, Nucleic acids research.
[58] L. A. Goodman,et al. Measures of association for cross classifications , 1979 .
[59] R. Simon,et al. Sample size determination in microarray experiments for class comparison and prognostic classification. , 2005, Biostatistics.
[60] Frank Preiswerk,et al. Stability of gene contributions and identification of outliers in multivariate analysis of microarray data , 2008, BMC Bioinformatics.
[61] E. Ashley. Towards precision medicine , 2016, Nature Reviews Genetics.
[62] Andrew H. Beck,et al. EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes , 2015, Bioinform..
[63] Arturo Araujo,et al. Cancer heterogeneity: converting a limitation into a source of biologic information , 2017, Journal of Translational Medicine.
[64] Ahmet Rasit Ozturk,et al. A resampling-based meta-analysis for detection of differential gene expression in breast cancer , 2008, BMC Cancer.
[65] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] Adrian V. Lee,et al. Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer , 2016, Clinical Cancer Research.
[67] R. Tibshirani,et al. Outlier sums for differential gene expression analysis. , 2007, Biostatistics.
[68] Li Li,et al. PADGE: analysis of heterogeneous patterns of differential gene expression. , 2007, Physiological genomics.
[69] Adam A. Margolin,et al. Empirical Bayes Analysis of Quantitative Proteomics Experiments , 2009, PloS one.
[70] Romdhane Rekaya,et al. LSOSS: Detection of Cancer Outlier Differential Gene Expression , 2010, Biomarker insights.
[71] Wen-Yuan Guo,et al. Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas , 2016, Oncotarget.
[72] Lily Ting,et al. Normalization and Statistical Analysis of Quantitative Proteomics Data Generated by Metabolic Labeling* , 2009, Molecular & Cellular Proteomics.